MicroPath Laboratories receives certification from CAP for Breast Prognostic Marker Factor Testing
Monday February 14, 2011
MicroPath Laboratories is now certified by The College of American Pathologists for Breast Prognostic Marker Factor Testing. This is a rare honor bestowed on only a few laboratories that meet the rigorous quality assessment and quality control standards established by The College of American Pathologists (CAP) and American Society for Clinical Oncologists (ASCO) for the testing of breast tissue samples for prognostic markers, including ER, PR,and HER2/neu.
###The College of American Pathologists is the world’s largest association comprised exclusively of pathologists. It is an organization concerned about patients and about providing the highest quality of patient care. The College stands firm in those beliefs and has developed CAP Public Statements on a variety of health issues related to pathology.For CAP information or resources, visit www.cap.org.
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 27,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. For ASCO information and resources, visit www.asco.org/presscenter. Patient-oriented cancer information is available at www.cancer.net.